Newstral
Article
The Times of India on 2020-09-22 14:42
SII starts production of Covid vaccine candidate
Related news
- India's Covid-19 vaccine candidate CovaxinThe Times of India
- COVID-19: DCGI nod to SII for phase 2 and 3 human clinical trials of Oxford vaccine candidateThe Hindu
- MModerna starts COVID-19 vaccine candidate testing on children, as U.S. cases and deaths tick upmarketwatch.com
- SII to start Phase II trials of Oxford Covid vaccineThe Times of India
- SII hopes to launch new COVID-19 vaccine by JuneThe Hindu
- China-made mRNA Covid vaccine targeting Omicron starts trial production, aims for 100 million doses in first phaseSouth China Morning Post
- SII to restart vaccine production amid surge in Covid casesThe Times of India
- Lonza starts ‘small-scale’ production of coronavirus vaccineSeacoastonline.com
- Venezuela Starts Clinical Trials for Russian Coronavirus Vaccine Candidatebreitbart.com
- Covid vaccine: Bharat Biotech starts clinical trialsThe Times of India
- SII commits to making 100 million more COVID-19 vaccine dosesThe Hindu
- Morocco starts construction of COVID vaccine plantAl Jazeera
- Chinese Covid-19 vaccine candidate sa...expressandstar.com
- Polestar 2 EV production starts in China despite COVID-19engadget
- COVAXIN, ZyCoV-D move to phase 2 trials; SII to begin testing for Oxford COVID-19 vaccine next weekherald.co.zw
- News24.com | Covid-19: UK inspecting SII vaccine site, possibly paving the way for AstraZeneca rollout - reportNews24
- America First? Covid-19 Vaccine Production & Exports [Infographic]Forbes
- What is being done to speed up Covid vaccine production?theweek.co.uk
- Suspend recruitment for vaccine trials, SII toldThe Times of India